CytoImmune Therapeutics logo

CytoImmune Therapeutics

CytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients.

31 employees · est. 2019 · Monrovia, United States

VS
Immunicom, Inc. logo

Immunicom, Inc.

Re-imagining healing without sacrifices.

25 employees · est. 2013 · San Diego, United States

Immunicom, Inc. is the older company (2019 vs 2013).

Side-by-Side Comparison

CytoImmune Therapeutics Immunicom, Inc.
Founded
2019 2013 older
Headquarters
Monrovia, United States San Diego, United States
Employees
31 25
Industry
Biotechnology, Health and Wellness Biotechnology
Funding Stage
Not tracked yet Grant
Total Funding
Not tracked yet $23.85M
Funding Rounds
Not tracked yet 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Immunotherapy, Bi-specific Antibody, CAR Technology, NK Cell Therapy, T-cell Therapy, Coordinated Immunotherapy, Cancer Treatment, Therapeutic Development, Immunology, Bispecific Antibody Therapy, Cell Therapy, Oncology, Innovative Treatment, Immune Response Immunotherapy, Cancer Therapy, Non-pharmaceutical Treatment, Innovative Therapy, Treatment Side Effects, Quality Of Life, Cost-effective Treatment, Autoimmune Diseases, Inflammatory Diseases, Non-drug-based Therapy, Therapy Response Rates, Immune System Enhancement, Cancer Treatment, Medical Innovation
Website
cytoimmune.com immunicom.com
CytoImmune Therapeutics logo

About CytoImmune Therapeutics

CytoImmune Therapeutics is a biotechnology startup with a vision to develop novel, coordinated immunotherapy solutions for patients. The company's CoalesceNT™ platform integrates bispecific antibody (biAb) and chimeric antigen receptor (CAR) technology to orchestrate an immune response with natural...

Immunicom, Inc. logo

About Immunicom, Inc.

Immunicom, Inc. is a biotechnology startup founded in 2013 in the United States. The company's slogan "Re-imagining healing without sacrifices" reflects its innovative approach to cancer therapy. Immunicom is focused on developing a non-drug-based cancer therapy that has the potential to significant...

We will tell you when either one moves

BounceWatch watches CytoImmune Therapeutics and Immunicom, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CytoImmune Therapeutic... and Immunicom, Inc. — by email.

Frequently Asked Questions

CytoImmune Therapeutics — CytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients.. Immunicom, Inc. — Re-imagining healing without sacrifices.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CytoImmune Therapeutics has raised undisclosed funding while Immunicom, Inc. has raised $23.85M.
CytoImmune Therapeutics and Immunicom, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CytoImmune Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CytoImmune Therapeutics on 18 Nov 2024, and Immunicom, Inc. on 15 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes